Associate Professor Mark Slee

  • Source: Scopus
  • Calculated based on no. of publications stored in Pure and citations from Scopus
20052020

Research activity per year

If you made any changes in Pure these will be visible here soon.

Search results

  • 2020

    Delay from treatment start to full effect of immunotherapies for multiple sclerosis

    Roos, I., Leray, E., Frascoli, F., Casey, R., Brown, J. W. L., Horakova, D., Havrdova, E. K., Trojano, M., Patti, F., Izquierdo, G., Eichau, S., Onofrj, M., Lugaresi, A., Prat, A., Girard, M., Grammond, P., Sola, P., Ferraro, D., Ozakbas, S., Bergamaschi, R. & 29 others, Sá, M. J., Cartechini, E., Boz, C., Granella, F., Hupperts, R., Terzi, M., Lechner-Scott, J., Spitaleri, D., Van Pesch, V., Soysal, A., Olascoaga, J., Prevost, J., Aguera-Morales, E., Slee, M., Csepany, T., Turkoglu, R., Sidhom, Y., Gouider, R., Van Wijmeersch, B., McCombe, P., Macdonell, R., Coles, A., Malpas, C. B., Butzkueven, H., Vukusic, S., Kalincik, T., MSBase , OFSEP investigators & Barnett, M., Sep 2020, In: Brain : a journal of neurology. 143, 9, p. 2742-2756 15 p.

    Research output: Contribution to journalArticlepeer-review

    2 Citations (Scopus)
  • Early clinical markers of aggressive multiple sclerosis

    MSBase Study Group, Manouchehrinia, A., Olsson, T. & Hillert, J., May 2020, In: Brain : a journal of neurology. 143, 5, p. 1400-1413 14 p.

    Research output: Contribution to journalArticlepeer-review

    5 Citations (Scopus)
  • Real-world effectiveness of cladribine for Australian patients with multiple sclerosis: An MSBase registry substudy

    Lizak, N., Hodgkinson, S., Butler, E., Lechner-Scott, J., Slee, M., McCombe, P. A., Shaw, C., Skibina, O., Vucic, S., Shuey, N., Barnett, M. H., Parratt, J., Butzkueven, H., Jack, D., Fabris, J. & Kalincik, T., 12 Jun 2020, (E-pub ahead of print) In: Multiple Sclerosis Journal. 27, 3, p. 465-474 10 p.

    Research output: Contribution to journalArticlepeer-review

    Open Access
    File
    1 Citation (Scopus)
    2 Downloads (Pure)
  • Relapse Patterns in NMOSD: Evidence for Earlier Occurrence of Optic Neuritis and Possible Seasonal Variation

    Khalilidehkordi, E., Clarke, L., Arnett, S., Bukhari, W., Jimenez Sanchez, S., O'Gorman, C., Sun, J., Prain, K. M., Woodhall, M., Silvestrini, R., Bundell, C. S., Abernethy, D., Bhuta, S., Blum, S., Boggild, M., Boundy, K., Brew, B. J., Brown, M., Brownlee, W., Butzkueven, H. & 46 others, Carroll, W. M., Chen, C., Coulthard, A., Dale, R. C., Das, C., Fabis-Pedrini, M. J., Fulcher, D., Gillis, D., Hawke, S., Heard, R., Henderson, A. P. D., Heshmat, S., Hodgkinson, S., Kilpatrick, T. J., King, J., Kneebone, C., Kornberg, A. J., Lechner-Scott, J., Lin, M. W., Lynch, C., Macdonell, R. A. L., Mason, D. F., McCombe, P. A., Pereira, J., Pollard, J. D., Ramanathan, S., Reddel, S. W., Shaw, C., Spies, J., Stankovich, J., Sutton, I., Vucic, S., Walsh, M., Wong, R. C., Yiu, E. M., Barnett, M. H., Kermode, A. G., Marriott, M. P., Parratt, J., Slee, M., Taylor, B. V., Willoughby, E., Brilot, F., Vincent, A., Waters, P. & Broadley, S. A., 16 Jun 2020, In: Frontiers in Neurology. 11, 8 p., 537.

    Research output: Contribution to journalArticlepeer-review

    Open Access
    File
    4 Citations (Scopus)
  • Risk of secondary progressive multiple sclerosis: a longitudinal study

    Fambiatos, A., Jokubaitis, V., Horakova, D., Kubala Havrdova, E., Trojano, M., Prat, A., Girard, M., Duquette, P., Lugaresi, A., Izquierdo, G., Grand’Maison, F., Grammond, P., Sola, P., Ferraro, D., Alroughani, R., Terzi, M., Hupperts, R., Boz, C., Lechner-Scott, J., Pucci, E. & 43 others, Bergamaschi, R., Van Pesch, V., Ozakbas, S., Granella, F., Turkoglu, R., Iuliano, G., Spitaleri, D., McCombe, P., Solaro, C., Slee, M., Ampapa, R., Soysal, A., Petersen, T., Sanchez-Menoyo, J. L., Verheul, F., Prevost, J., Sidhom, Y., Van Wijmeersch, B., Vucic, S., Cristiano, E., Saladino, M. L., Deri, N., Barnett, M., Olascoaga, J., Moore, F., Skibina, O., Gray, O., Fragoso, Y., Yamout, B., Shaw, C., Singhal, B., Shuey, N., Hodgkinson, S., Altintas, A., Al-Harbi, T., Csepany, T., Taylor, B., Hughes, J., Jun, J. K., van der Walt, A., Spelman, T., Butzkueven, H. & Kalincik, T., 1 Jan 2020, In: Multiple Sclerosis Journal. 26, 1, p. 79-90 12 p.

    Research output: Contribution to journalArticlepeer-review

    12 Citations (Scopus)
  • The clinical profile of NMOSD in Australia and New Zealand

    Bukhari, W., Clarke, L., O’Gorman, C., Khalilidehkordi, E., Arnett, S., Prain, K. M., Woodhall, M., Silvestrini, R., Bundell, C. S., Ramanathan, S., Abernethy, D., Bhuta, S., Blum, S., Boggild, M., Boundy, K., Brew, B. J., Brownlee, W., Butzkueven, H., Carroll, W. M., Chen, C. & 46 others, Coulthard, A., Dale, R. C., Das, C., Dear, K., Fabis-Pedrini, M. J., Fulcher, D., Gillis, D., Hawke, S., Heard, R., Henderson, A. P. D., Heshmat, S., Hodgkinson, S., Jimenez-Sanchez, S., Kilpatrick, T. J., King, J., Kneebone, C., Kornberg, A. J., Lechner-Scott, J., Lin, M. W., Lynch, C., Macdonnell, R. A. L., Mason, D. F., McCombe, P. A., Pereira, J., Pollard, J. D., Reddel, S. W., Shaw, C., Spies, J., Stankovich, J., Sutton, I., Vucic, S., Walsh, M., Wong, R. C., Yiu, E. M., Barnett, M. H., Kermode, A. G., Marriott, M. P., Parratt, J., Slee, M., Taylor, B. V., Willoughby, E., Wilson, R. J., Brilot, F., Vincent, A., Waters, P. & Broadley, S. A., 1 May 2020, In: Journal of Neurology. 267, 5, p. 1431-1443 13 p.

    Research output: Contribution to journalArticlepeer-review

    2 Citations (Scopus)
  • 2019

    A Neuroethics Framework for the Australian Brain Initiative

    Australian Brain Alliance, Cohen-Woods, S., Conn, S., Licinio, J. & Slee, M., 6 Feb 2019, In: NEURON. 101, 3, p. 365-369 5 p.

    Research output: Contribution to journalArticlepeer-review

    2 Citations (Scopus)
  • Anti-inflammatory disease-modifying treatment and disability progression in primary progressive multiple sclerosis: a cohort study

    Lorscheider, J., Kuhle, J., Izquierdo, G., Lugaresi, A., Havrdova, E., Horakova, D., Hupperts, R., Duquette, P., Girard, M., Prat, A., Grand'Maison, F., Grammond, P., Sola, P., Ferraro, D., Trojano, M., Ramo-Tello, C., Lechner-Scott, J., Pucci, E., Solaro, C., Slee, M. & 7 others, Van Pesch, V., Sanchez Menoyo, J. L., van der Walt, A., Butzkueven, H., Kappos, L., Kalincik, T. & MSBase Study Group, 1 Feb 2019, In: European Journal of Neurology. 26, 2, p. 363-370 8 p.

    Research output: Contribution to journalArticlepeer-review

    4 Citations (Scopus)
  • Association of Initial Disease-Modifying Therapy with Later Conversion to Secondary Progressive Multiple Sclerosis

    Brown, J. W. L., Coles, A., Horakova, D., Havrdova, E., Izquierdo, G., Prat, A., Girard, M., Duquette, P., Trojano, M., Lugaresi, A., Bergamaschi, R., Grammond, P., Alroughani, R., Hupperts, R., McCombe, P., Van Pesch, V., Sola, P., Ferraro, D., Grand'Maison, F., Terzi, M. & 21 others, Lechner-Scott, J., Flechter, S., Slee, M., Shaygannejad, V., Pucci, E., Granella, F., Jokubaitis, V., Willis, M., Rice, C., Scolding, N., Wilkins, A., Pearson, O. R., Ziemssen, T., Hutchinson, M., Harding, K., Jones, J., McGuigan, C., Butzkueven, H., Kalincik, T., Robertson, N. & MSBase Study Group, 15 Jan 2019, In: JAMA - Journal of the American Medical Association. 321, 2, p. 175-187 13 p.

    Research output: Contribution to journalArticlepeer-review

    86 Citations (Scopus)
  • Comparison of fingolimod, dimethyl fumarate and teriflunomide for multiple sclerosis

    Kalincik, T., Kubala Havrdova, E., Horakova, D., Izquierdo, G., Prat, A., Girard, M., Duquette, P., Grammond, P., Onofrj, M., Lugaresi, A., Ozakbas, S., Kappos, L., Kuhle, J., Terzi, M., Lechner-Scott, J., Boz, C., Grand'maison, F., Prevost, J., Sola, P., Ferraro, D. & 24 others, Granella, F., Trojano, M., Bergamaschi, R., Pucci, E., Turkoglu, R., McCombe, P. A., Pesch, V. V., Van Wijmeersch, B., Solaro, C., Ramo-Tello, C., Slee, M., Alroughani, R., Yamout, B., Shaygannejad, V., Spitaleri, D., Sánchez-Menoyo, J. L., Ampapa, R., Hodgkinson, S., Karabudak, R., Butler, E., Vucic, S., Jokubaitis, V., Spelman, T. & Butzkueven, H., 1 Apr 2019, In: Journal of Neurology, Neurosurgery and Psychiatry. 90, 4, p. 458-468 11 p.

    Research output: Contribution to journalArticlepeer-review

    26 Citations (Scopus)
  • Incidence of pregnancy and disease-modifying therapy exposure trends in women with multiple sclerosis: A contemporary cohort study

    Barnett, M. & MSBase Study Group, 1 Feb 2019, In: Multiple Sclerosis and Related Disorders. 28, p. 235-243 9 p.

    Research output: Contribution to journalArticlepeer-review

    12 Citations (Scopus)
  • Relapsing necrotising encephalomyelopathy due to RANBP2 mutation

    Kelly, E., Harvey, J., Brion, K., Fletcher, J. & Slee, M., 22 Feb 2019, In: Practical Neurology. 19, 4, p. 360-363 4 p.

    Research output: Contribution to journalArticlepeer-review

    4 Citations (Scopus)
  • The Northern Territory Medical Program: growing our own in the NT

    Worley, P., Lowe, M., Notaras, L., Strasser, S., Kidd, M., Slee, M., Williams, R., Noutsos, T. & Wakerman, J., 1 May 2019, In: Rural and Remote Health. 19, 2, 6 p., 4671.

    Research output: Contribution to journalArticlepeer-review

    Open Access
    File
    1 Citation (Scopus)
    9 Downloads (Pure)
  • 2018

    Association of Inflammation and Disability Accrual in Patients with Progressive-Onset Multiple Sclerosis

    MSBase Study Group, 1 Nov 2018, In: JAMA Neurology. 75, 11, p. 1407-1415 9 p.

    Research output: Contribution to journalArticlepeer-review

    7 Citations (Scopus)
  • Cladribine versus fingolimod, natalizumab and interferon β for multiple sclerosis

    MSBase Study Group, 1 Oct 2018, In: Multiple Sclerosis Journal. 24, 12, p. 1617-1626 10 p.

    Research output: Contribution to journalArticlepeer-review

    10 Citations (Scopus)
  • Long-term disability trajectories in primary progressive MS patients: A latent class growth analysis

    Signori, A., Izquierdo, G., Lugaresi, A., Hupperts, R., Grand’Maison, F., Sola, P., Horakova, D., Havrdova, E., Prat, A., Girard, M., Duquette, P., Boz, C., Grammond, P., Terzi, M., Singhal, B., Alroughani, R., Petersen, T., Ramo, C., Oreja-Guevara, C., Spitaleri, D. & 22 others, Shaygannejad, V., Butzkueven, H., Kalincik, T., Jokubaitis, V., Slee, M., Fernandez Bolaños, R., Sanchez-Menoyo, J. L., Pucci, E., Granella, F., Lechner-Scott, J., Iuliano, G., Hughes, S., Bergamaschi, R., Taylor, B., Verheul, F., Edite Rio, M., Amato, M. P., Sajedi, S. A., Majdinasab, N., Van Pesch, V., Sormani, M. P. & Trojano, M., 1 Apr 2018, In: Multiple Sclerosis Journal. 24, 5, p. 642-652 11 p.

    Research output: Contribution to journalArticlepeer-review

    18 Citations (Scopus)
  • 2017

    Contribution of different relapse phenotypes to disability in multiple sclerosis

    Stewart, T., Spelman, T., Havrdova, E., Horakova, D., Trojano, M., Izquierdo, G., Duquette, P., Girard, M., Prat, A., Lugaresi, A., Grand' Maison, F., Grammond, P., Sola, P., Shaygannejad, V., Hupperts, R., Alroughani, R., Oreja-Guevara, C., Pucci, E., Boz, C., Lechner-Scott, J. & 35 others, Bergamaschi, R., Van Pesch, V., Iuliano, G., Ramo, C., Taylor, B., Slee, M., Spitaleri, D., Granella, F., Verheul, F., McCombe, P., Hodgkinson, S., Amato, M., Vucic, S., Gray, O., Cristiano, E., Barnett, M., Menoyo, J., van Munster, E., Saladino, M., Olascoaga, J., Prevost, J., Deri, N., Shaw, C., Singhal, B., Moore, F., Rozsa, C., Shuey, N., Skibina, O., Kister, I., Petkovska-Boskova, T., Ampapa, R., Kermode, A., Butzkueven, H., Jokubaitis, V. & Kalincik, T., 1 Feb 2017, In: Multiple Sclerosis. 23, 2, p. 266-276 11 p.

    Research output: Contribution to journalArticlepeer-review

    22 Citations (Scopus)
  • Data quality evaluation for observational multiple sclerosis registries

    Kalincik, T., Kuhle, J., Pucci, E., Rojas, J. I., Tsolaki, M., Sirbu, C. A., Slee, M., Butzkueven, H. & MSBase Scientific Leadership Group and MSBase Study Group, 1 Apr 2017, In: Multiple Sclerosis. 23, 5, p. 647-655 9 p.

    Research output: Contribution to journalArticlepeer-review

    33 Citations (Scopus)
  • Highly active immunomodulatory therapy ameliorates accumulation of disability in moderately advanced and advanced multiple sclerosis

    Lizak, N., Lugaresi, A., Alroughani, R., Lechner-Scott, J., Slee, M., Havrdova, E., Horakova, D., Trojano, M., Izquierdo, G., Duquette, P., Girard, M., Prat, A., Grammond, P., Hupperts, R., Grand'Maison, F., Sola, P., Pucci, E., Bergamaschi, R., Oreja-Guevara, C., Van Pesch, V. & 17 others, Ramo, C., Spitaleri, D., Iuliano, G., Boz, C., Granella, F., Olascoaga, J., Verheul, F., Rozsa, C., Cristiano, E., Flechter, S., Hodgkinson, S., Amato, M., Deri, N., Jokubaitis, V., Spelman, T., Butzkueven, H. & Kalincik, T., 1 Mar 2017, In: Journal of Neurology, Neurosurgery & Psychiatry. 88, 3, p. 196-203 8 p.

    Research output: Contribution to journalArticlepeer-review

    33 Citations (Scopus)
  • Incidence and prevalence of NMOSD in Australia and New Zealand

    Bukhari, W., Prain, K., Waters, P., Woodhall, M., O'Gorman, C., Clarke, L., Silvestrini, R., Bundell, C., Abernethy, D., Bhuta, S., Blum, S., Boggild, M., Boundy, K., Brew, B. J., Brown, M., Brownlee, W., Butzkueven, H., Carroll, W., Chen, C., Coulthard, A. & 44 others, Dale, R., Das, C., Dear, K., Fabis-Pedrini, M., Fulcher, D., Gillis, D., Hawke, S., Heard, R., Henderson, A. P. D., Heshmat, S., Hodgkinson, S., Jimenez-Sanchez, S., Killpatrick, T., King, J., Kneebone, C., Kornberg, A., Lechner-Scott, J., Lin, M-W., Lynch, C., Macdonell, R., Mason, D. F., McCombe, P., Pender, M., Pereira, J., Pollard, J., Reddel, S., Shaw, C., Spies, J., Stankovich, J., Sutton, I., Vucic, S., Walsh, M., Wong, R. C., Yiu, E., Barnett, M., Kermode, A., Marriott, M., Parratt, J., Slee, M., Taylor, B., Willoughby, E., Wilson, R., Vincent, A. & Broadly, S., 1 Aug 2017, In: Journal of Neurology, Neurosurgery & Psychiatry. 88, 8, p. 632-638 7 p.

    Research output: Contribution to journalArticlepeer-review

    45 Citations (Scopus)
  • Prognostic indicators in pediatric clinically isolated syndrome

    Spelman, T., Italian iMedWeb Registry and the MSBase Registry, Barnett, M. & Slee, M., 1 May 2017, In: Annals of Neurology. 81, 5, p. 729-739 11 p.

    Research output: Contribution to journalArticlepeer-review

    23 Citations (Scopus)
  • Response to interferon-beta treatment in multiple sclerosis patients: A genome-wide association study

    Mahurkar, S., Moldovan, M., Suppiah, V., Sorosina, M., Clarelli, F., Liberatore, G., Malhotra, S., Montalban, X., Antigüedad, A., Krupa, M., Jokubaitis, V. G., McKay, F. C., Gatt, P. N., Fabis-Pedrini, M. J., Martinelli, V., Comi, G., Lechner-Scott, J., Kermode, A. G., Slee, M., Taylor, B. V. & 5 others, Vandenbroeck, K., Comabella, M., Boneschi, F. M., Australian and New Zealand Multiple Sclerosis Genetics Consortium (ANZgene) & King, C., 1 Jul 2017, In: PHARMACOGENOMICS JOURNAL. 17, 4, p. 312-318 7 p.

    Research output: Contribution to journalArticlepeer-review

    16 Citations (Scopus)
  • Towards personalized therapy for multiple sclerosis: Prediction of individual treatment response

    Kalincik, T., Manouchehrinia, A., Sobisek, L., Jokubaitis, V., Spelman, T., Horakova, D., Havrdova, E., Trojano, M., Izquierdo, G., Lugaresi, A., Girard, M., Prat, A., Duquette, P., Grammond, P., Sola, P., Hupperts, R., Grand'Maison, F., Pucci, E., Boz, C., Alroughani, R. & 28 others, Van Pesch, V., Lechner-Scott, J., Terzi, M., Bergamaschi, R., Iuliano, G., Granella, F., Spitaleri, D., Shaygannejad, V., Oreja-Guevara, C., Slee, M., Ampapa, R., Verheul, F., McCombe, P., Olascoaga, J., Amato, M. P., Vucic, S., Hodgkinson, S., Ramo-Tello, C., Flechter, S., Cristiano, E., Rozsa, C., Moore, F., Sanchez-Menoyo, J. L., Saladino, M. L., Barnett, M., Hillert, J., Butzkueven, H. & MS Base Study Group, 1 Sep 2017, In: Brain. 140, 9, p. 2426-2443 18 p.

    Research output: Contribution to journalArticlepeer-review

    Open Access
    40 Citations (Scopus)
  • Treatment effectiveness of alemtuzumab compared with natalizumab, fingolimod, and interferon beta in relapsing-remitting multiple sclerosis: a cohort study

    Kalincik, T., Brown, J. W., Robertson, N., Willis, M., Scolding, N., Rice, C., Wilkins, A., Pearson, O., Ziemssen, T., Hutchinson, M., McGuigan, C., Jokubaitis, V., Spelman, T., Horakova, D., Trojano, M., Izquierdo, G., Lugaresi, A., Prat, A., Girard, M., Duquette, P. & 29 others, Grammond, P., Alroughani, R., Pucci, E., Sola, P., Hupperts, R., Lechner-Scott, J., Terzi, M., Van Pesch, V., Rozsa, C., Grand'Maison, F., Boz, C., Granella, F., Slee, M., Spitaleri, D., Olascoaga, J., Bergamaschi, R., Verheul, F., Vucic, S., McCombe, P., Hodgkinson, S., Sanchez-Menoyo, J., Ampapa, R., Simo, M., Csepany, T., Ramo, C., Cristiano, E., Barnett, M., Butzkueven, H. & Coles, A., Apr 2017, In: Lancet Neurology. 16, 4, p. 271-281 11 p.

    Research output: Contribution to journalArticlepeer-review

    83 Citations (Scopus)
  • 2016
    Open Access
    File
    12 Citations (Scopus)
  • CSF hypotension: A review of its manifestations, investigation and management

    Pattichis, A. & Slee, M., 1 Dec 2016, In: Journal of Clinical Neuroscience. 34, p. 39-43 5 p.

    Research output: Contribution to journalReview articlepeer-review

    22 Citations (Scopus)
  • Defining secondary progressive multiple sclerosis

    Lorscheider, J., Buzzard, K., Jokubaitis, V., Spelman, T., Havrdova, E., Horakova, D., Trojano, M., Izquierdo, G., Girard, M., Duquette, P., Prat, A., Lugaresi, A., Grand'Maison, F., Grammond, P., Hupperts, R., Alroughani, R., Sola, P., Boz, C., Pucci, E., Lechner-Scott, J. & 25 others, Bergamaschi, R., Oreja-Guevara, C., Iuliano, G., Van Pesch, V., Granella, F., Ramo-Tello, C., Spitaleri, D., Petersen, T., Slee, M., Verheul, F., Ampapa, R., Amato, M., McCombe, P., Vucic, S., Sanchez-Menoyo, J., Christiano, E., Barnett, M., Hodgkinson, S., Olascoaga, J., Saladino, M., Gray, O., Shaw, C., Moore, F., Butzkueven, H. & Kalincik, T., 1 Sep 2016, In: Brain. 139, 9, p. 2395-2405 11 p.

    Research output: Contribution to journalArticlepeer-review

    121 Citations (Scopus)
  • Discontinuing disease-modifying therapy in MS after a prolonged relapse-free period: a propensity score-matched study

    Kister, I., Spelman, T., Alroughani, R., Lechner-Scott, J., Duquette, P., Grand'Maison, F., Slee, M., Lugaresi, A., Barnett, M., Grammond, P., Iuliano, G., Hupperts, R., Pucci, E., Trojano, M. & Butzkueven, H., 1 Oct 2016, In: Journal of Neurology, Neurosurgery & Psychiatry. 87, 10, p. 1133-1137 5 p.

    Research output: Contribution to journalArticlepeer-review

    47 Citations (Scopus)
  • Higher latitude is significantly associated with an earlier age of disease onset in multiple sclerosis

    Tao, C., Simpson, S., I, V., Blizzard, L., Havrdova, E., Horakova, D., Shaygannejad, V., Lugaresi, A., Izquierdo, G., Trojano, M., Duquette, P., Girard, M., Grand'Maison, F., Grammond, P., Alroughani, R., Terzi, M., Oreja-Guevara, C., Sajedi, S. A., Iuliano, G., Sola, P. & 28 others, Lechner-Scott, J., Van Pesch, V., Pucci, E., Bergamaschi, R., Barnett, M., Ramo, C., Singhal, B., Spitaleri, D., Slee, M., Verheul, F., Fernandez-Bolanos, R., Amato, M., Cristiano, E., Granella, F., Hodgkinson, S., Fiol, M., Gray, O., McCombe, P., Saladino, M., Sanchez-Menoyo, J., Shuey, N., Vucic, S., Shaw, C., Deri, N., Oleschko Arruda, W., Butzkueven, H., Spelman, T. & Taylor, B., 1 Dec 2016, In: Journal of Neurology, Neurosurgery & Psychiatry. 87, 12, p. 1343-1349 7 p.

    Research output: Contribution to journalArticlepeer-review

    35 Citations (Scopus)
  • The effect of oral immunomodulatory therapy on treatment uptake and persistence in multiple sclerosis

    Warrender-Sparkes, M., Spelman, T., Izquierdo, G., Trojano, M., Lugaresi, A., Grand'Maison, F., Havrdova, E., Horakova, D., Boz, C., Oreja-Guevara, C., Alroughani, R., Iuliano, G., Duquette, P., Girard, M., Terzi, M., Hupperts, R., Grammond, P., Petersen, T., Fernandez-Bolanos, R., Fiol, M. & 21 others, Pucci, E., Lechner-Scott, J., Verheul, F., Cristiano, E., Van Pesch, V., Petkovska-Boskova, T., Moore, F., Kister, I., Bergamaschi, R., Saladino, M., Slee, M., Barnett, M., Amato, M., Shaw, C., Shuey, N., Young, C., Gray, O., Kappos, L., Butzkeuven, H., Kalincik, T. & Jokubaitis, V., 2016, In: Multiple Sclerosis. 22, 4, p. 520-532 13 p.

    Research output: Contribution to journalArticlepeer-review

    24 Citations (Scopus)
  • 2015

    A new era in the treatment of multiple sclerosis

    Broadley, S., Barnett, M., Boggild, M., Brew, B., Butzkueven, H., Heard, R., Hodgkinson, S., Kermode, A., Lechner-Scott, J., Macdonell, R., Marriott, M., Mason, D., Parratt, J., Reddel, S., Shaw, C., Slee, M., Sples, J., Taylor, B., Carroll, W., Killpatrick, T. & 4 others, King, J., McCombe, P., Pollard, J. & Willoughby, E., 3 Aug 2015, In: Medical Journal of Australia. 203, 3, p. 139-141 3 p.

    Research output: Contribution to journalArticlepeer-review

    8 Citations (Scopus)
  • A rare P2X7 variant Arg307Gln with absent pore formation function protects against neuroinflammation in multiple sclerosis

    Gu, B. J., Field, J., Dutertre, S., Ou, A., Kilpatrick, T. J., Lechner-Scott, J., Scott, R., Lea, R., Taylor, B. V., Stankovich, J., Butzkueven, H., Gresle, M., Laws, S. M., Petrou, S., Hoffjan, S., Akkad, D. A., Graham, C. A., Hawkins, S., Glaser, A., Bedri, S. K. & 8 others, Hillert, J., Matute, C., Antiguedad, A., Wiley, J. S., ANZgene, Baxter, A. G., Slee, M. & Barnett, M. H., 1 Oct 2015, In: Human Molecular Genetics. 24, 19, p. 5644-5654 11 p.

    Research output: Contribution to journalArticlepeer-review

    31 Citations (Scopus)
  • Comparative effectiveness of glatiramer acetate and interferon beta formulations in relapsing – remitting multiple sclerosis

    Kalincik, T., Jokubaitis, V., Izquierdo, G., Duquette, P., Girard, M., Grammond, P., Lugaresi, A., Oreja-Guevara, C., Bergamaschi, R., Hupperts, R., Grand'Maison, F., Pucci, E., Van Pesch, V., Boz, C., Iuliano, G., Fernandez-Bolanos, R., Fletcher, S., La Spitaleri, D., Cristiano, E., Verheul, F. & 14 others, Lechner-Scott, J., Amato, M., Cabrera-Gomez, J., Saladino, M., Slee, M., Moore, F., Gray, O., Paine, M., Barnett, M., Havrdova, E., Horakova, D., Spelman, T., Trojano, M. & Butzkueven, H., 25 Aug 2015, In: Multiple Sclerosis. 21, 9, p. 1159-1171 13 p.

    Research output: Contribution to journalArticlepeer-review

    29 Citations (Scopus)
  • Comparison of switch to fingolimod or interferon beta/glatiramer acetate in active multiple sclerosis

    MSBase Study Group, He, A., Spelman, T., Jokubaitis, V., Havrdova, E., Horakova, D., Trojano, M., Lugaresi, A., Izquierdo, G., Grammond, P., Duquette, P., Girard, M., Pucci, E., Iuliano, G., Alroughani, R., Oreja-Guevara, C., Fernandez-Bolaños, R., Grand'Maison, F., Sola, P., Spitaleri, D. & 13 others, Granella, F., Terzi, M., Lechner-Scott, J., Van Pesch, V., Hupperts, R., Sánchez-Menoyo, J. L., Hodgkinson, S., Rozsa, C., Verheul, F., Butzkueven, H., Kalincik, T., Slee, M. & Barnett, M., 25 Jun 2015, In: JAMA Neurology. 72, 4, p. 405-413 9 p.

    Research output: Contribution to journalArticlepeer-review

    85 Citations (Scopus)
  • Defining reliable disability outcomes in multiple sclerosis

    Kalincik, T., Cutter, G., Spelman, T., Jokubaitis, V., Havrdova, E., Horakova, D., Trojano, M., Izquierdo, G., Girard, M., Duquette, P., Prat, A., Lugaresi, A., Grand'Maison, F., Grammond, P., Hupperts, R., Oreja-Guevara, C., Boz, C., Pucci, E., Bergamaschi, R., Lechner-Scott, J. & 16 others, Alroughani, R., Van Pesch, V., Iuliano, G., Fernandez-Bolanos, R., Ramo, C., Terzi, M., Slee, M., Spitaleri, D., Verheul, F., Cristiano, E., Sanchez-Menoyo, J., Fiol, M., Gray, O., Cabrera-Gomez, J., Barnett, M. & Butzkueven, H., 2015, In: Brain. 138, 11, p. 3287-3298 12 p.

    Research output: Contribution to journalArticlepeer-review

    79 Citations (Scopus)
  • Genetic variants are major determinants of CSF antibody levels in multiple sclerosis

    Goris, A., Pauwels, I., Gustavsen, M. W., Van Son, B., Hilven, K., Box, S. D., Celius, E., Berg-Hansen, P., Aarseth, J., Myhr, K-M., D'Alfonso, S., Barizzone, N., Leone, M., Martinelli-Boneschi, F., Sorosina, M., Liberatore, G., Kockum, I., Olsson, T., Hillert, J., Alfredsson, L. & 26 others, Bedri, S., Hemmer, B., Buck, D., Berthele, A., Knier, B., Biberacher, V., Van Pesch, V., Sindic, C., Oturai, A., Sondergaard, H., Sellebjerg, F., Jensen, P. H., Comabella, M., Montalban, X., Perez-Boza, J., Malhotra, S., Lechner-Scott, J., Broadley, S., Slee, M., Taylor, B., Kermode, A., Gourraud, P-A., Sawcer, S., Andreassen, B., Dubois, B. & Harbo, H., 1 Mar 2015, In: Brain. 138, 3, p. 632-643 12 p.

    Research output: Contribution to journalArticlepeer-review

    38 Citations (Scopus)
  • Increased platelet extracellular vesicle release and platelet mitochondrial bioenergetic changes in relapsing Multiple Sclerosis (MS)

    Krupa, M., Michael, M., McNicholas, K., Sims, N., Barlow, S., Green, A., Bailey, S., Macardle, C. & Slee, M., 6 Nov 2015, In: Multiple Sclerosis. 21, 14, p. NP9-NP10 2 p.

    Research output: Contribution to journalArticlepeer-review

  • Late effects of oxaliplatin-induced peripheral neuropathy (LEON)—cross-sectional cohort study of patients with colorectal cancer surviving at least 2 years

    Padman, S., Lee, J., kumar, R., Slee, M., Hakendorf, P., Richards, A., Koczwara, B., Kichenadasse, G., Sukumaran, S., Roy, A., Vatandoust, S. & Karapetis, C., Mar 2015, In: Supportive Care in Cancer. 23, 3, p. 861-869 9 p.

    Research output: Contribution to journalArticlepeer-review

    21 Citations (Scopus)
  • Male Sex Is Independently Associated with Faster Disability Accumulation in Relapse-Onset MS but Not in Primary Progressive MS

    Ribbons, K., McElduff, P., Boz, C., Trojano, M., Izquierdo, G., Duquette, P., Girard, M., Grand'Maison, F., Hupperts, R., Grammond, P., Oreja-Guevara, C., Petersen, T., Bergamaschi, R., Guiliani, G., Barnett, M., Van Pesch, V., Amato, M., Iuliano, G., Slee, M., Fiol, M. & 16 others, Verheul, F., Cristiano, E., Fernandez-Bolanos, R., Saladino, M-L., Rio, M., Cabrera-Gomez, J., Butzkueven, H., van Munster, E., den Braber-Moerland, L., La Spitaleri, D., Lugaresi, A., Shaygannejad, V., Gray, O., Deri, N., Alroughani, R. & Lechner-Scott, J., 5 Jun 2015, In: PLoS One. 10, 6, p. Art: e0122686 11 p., e0122686.

    Research output: Contribution to journalArticlepeer-review

    59 Citations (Scopus)
  • Predictors of disability worsening in clinically isolated syndrome

    Jokubaitis, V., Spelman, T., Kalincik, T., Izquierdo, G., Grand'Maison, F., Duquette, P., Girard, M., Lugaresi, A., Grammond, P., Hupperts, R., Cabrera-Gomez, J., Oreja-Guevara, C., Boz, C., Giuliani, G., Fernandez-Bolanos, R., Iuliano, G., Lechner-Scott, J., Verheul, F., Van Pesch, V., Petkovska-Boskova, T. & 16 others, Fiol, M., Moore, F., Cristiano, E., Alroughani, R., Bergamaschi, R., Barnett, M., Slee, M., Vella, N., Herbert, J., Shaw, C., Saladino, M., Amato, M., Liew, D., Paolicelli, D., Butzkueven, H. & Trojano, M., 1 May 2015, In: Annals of Clinical and Translational Neurology. 2, 5, p. 479-491 13 p.

    Research output: Contribution to journalArticlepeer-review

    29 Citations (Scopus)
  • Switch to natalizumab versus fingolimod in active relapsing–remitting multiple sclerosis

    Kalincik, T., Horakova, D., Spelman, T., Jokubaitis, V., Trojano, M., Lugaresi, A., Izquierdo, G., Rozsa, C., Grammond, P., Alroughani, R., Duquette, P., Girard, M., Pucci, E., Lechner-Scott, J., Slee, M., Fernandez-Bolanos, R., Grand'Maison, F., Hupperts, R., Verheul, F., Hodgkinson, S. & 13 others, Oreja-Guevara, C., Spitaleri, D., Barnett, M., Terzi, M., Bergamaschi, R., McCombe, P., Sanchez-Menoyo, J., Simo, M., Csepany, T., Rum, G., Boz, C., Havrdova, E. & Butzkeuven, H., 1 Mar 2015, In: Annals of Neurology. 77, 3, p. 425-435 11 p.

    Research output: Contribution to journalArticlepeer-review

    113 Citations (Scopus)
  • The MS risk allele of CD40 is associated with reduced cell-membrane bound expression in antigen presenting cells: Implications for gene function

    Field, J., Shahijanian, F., Schibeci, S., Australian and New Zealand Multiple Sclerosis Genetics Consortium (ANZgene), Johnson, L., Gresle, M., Laverick, L., Parnell, G., Stewart, G. J., McKay, F., Kilpatrick, T., Butzkueven, H., Booth, D., Baxter, A., Kermode, A. G., Taylor, B., Booth, D. R., Mason, D., Stewart, G. J., Charlesworth, J. & 11 others, Wiley, J., Lechner-Scott, J., Tajouri, L., Griffiths, L., Slee, M., Brown, M. A., Moscato, P., Scott, R. J., Broadley, S., Vucic, S. & Carroll, W. M., 11 Jun 2015, In: PLoS One. 10, 6, 14 p., e0127080.

    Research output: Contribution to journalArticlepeer-review

    Open Access
    File
    24 Citations (Scopus)
  • 2014

    Fingolimod after natalizumab and the risk of short-term relapse

    Jokubaitis, V., Li, V., Kalincik, T., Izquierdo, G., Hodgkinson, S., Alroughani, R., Lechner-Scott, J., Lugaresi, A., Duquette, P., Girard, M., Barnett, M., Grand'Maison, F., Trojano, M., Slee, M., Giuliani, G., Shaw, C., Boz, C., La Spitaleri, D., Verheul, F., Haartsen, J. & 2 others, Liew, D. & Butzkueven, H., 8 Apr 2014, In: Neurology. 82, 14, p. 1204-1211 8 p.

    Research output: Contribution to journalArticlepeer-review

    109 Citations (Scopus)
  • Oral teriflunomide for patients with relapsing multiple sclerosis (TOWER): a randomised, double-blind, placebo-controlled, phase 3 trial

    Confavreux, C., O'Connor, P., Comi, G., Freedman, M., Miller, A., Olsson, T., Wolinsky, J., Bagulho, T., Delhay, J-L., Dukovic, D., Truffinet, P., Kappos, L., TOWER TRIAL GROUP, TOWER. TRIAL. GROUP. & Slee, M., Mar 2014, In: Lancet Neurology. 13, 3, p. 247-256 10 p.

    Research output: Contribution to journalArticlepeer-review

    301 Citations (Scopus)
  • Predictors and dynamics of postpartum relapses in women with multiple sclerosis

    Hughes, S., Spelman, T., Gray, O., Boz, C., Trojano, M., Lugaresi, A., Izquierdo, G., Duquette, P., Girard, M., Grand'Maison, F., Grammond, P., Oreja-Guevara, C., Hupperts, R., Bergamaschi, R., Giuliani, G., Lechner-Scott, J., Barnett, M., Rio, M., Van Pesch, V., Amato, M. & 21 others, Iuliano, G., Slee, M., Verheul, F., Cristiano, E., Fernandez-Bolanos, R., Poehlau, D., Saladino, M., Deri, N., Cabrera-Gomez, J., Vella, N., Herbert, J., Skromme, E., Savino, A., Shaw, C., Moore, F., Vucic, S., Petkovska-Boskova, T., McDonnell, G., Hawkins, S., Kee, F. & Butzkueven, H., May 2014, In: Multiple Sclerosis. 20, 6, p. 739-746 8 p.

    Research output: Contribution to journalArticlepeer-review

    88 Citations (Scopus)
  • Ribosomal protein S6 mRNA is a biomarker upregulated in multiple sclerosis, downregulated by interferon treatment, and affected by season

    Parnell, G., Gatt, P., McKay, F., Schibeci, S., Krupa, M., Powell, J., Visscher, P., Montgomery, G., Lechner-Scott, J., Broadley, S., Liddle, C., Slee, M., Vucic, S., Stewart, G. & Booth, D., May 2014, In: Multiple Sclerosis. 20, 6, p. 675-685 11 p.

    Research output: Contribution to journalArticlepeer-review

    14 Citations (Scopus)
  • Risk of relapse phenotype recurrence in multiple sclerosis

    Kalincik, T., Buzzard, K., Jokubaitis, V., Trojano, M. A., Duquette, P., Izquierdo, G., Girard, M., Lugaresi, A., Grammond, P., Grand'Maison, F., Oreja-Guevara, C., Boz, C., Hupperts, R., Petersen, T., Guiliani, G., Iuliano, G., Lechner-Scott, J., Barnett, M., Bergamaschi, R., Amato, M. & 28 others, van Munster, E., Fernandez-Bolanos, R., Fiol, M., Verheul, F., Van Pesch, V., Cristiano, E., Rio, M., Slee, M., Spitaleri, D., Alroughani, R., Gray, O., Saladino, M., Fletcher, S., Herbert, J., Cabrera-Gomez, J., Vella, N., Paine, M., Shaw, C., Moore, F., Vucic, S., Savino, A., Singhal, B., Petkovska-Boskova, T., Parratt, J., Sirbu, C-A., Rozsa, C., Liew, D. & Butzkueven, H., 19 Oct 2014, In: Multiple Sclerosis. 20, 11, p. 1511-1522 12 p.

    Research output: Contribution to journalArticlepeer-review

    43 Citations (Scopus)
  • Seasonal Variation of Relapse Rate in Multiple Sclerosis is Latitude Dependent

    Spelman, T., Gray, O., Trojano, M., Petersen, T., Izquierdo, G., Lugaresi, A., Hupperts, R., Bergamaschi, R., Duquette, P., Grammond, P., Guiliani, G., Boz, C., Verheul, F., Oreja-Guevara, C., Barnett, M., Grand'Maison, F., Rio, M., Lechner-Scott, J., Van Pesch, V., Fernandez-Bolanos, R. & 25 others, Fletcher, S., den Braber-Moerland, L., Iuliano, G., Amato, M., Slee, M., Cristiano, E., Saladino, M., Paine, M., Vella, N., Kasa, K., Deri, N., Herbert, J., Moore, F., Petkovska-Boskova, T., Alroughani, R., Savino, A., Shaw, C., Vucic, S., Santiago, V., Bacile, E., Skromne, E., Poehlau, D., Cabrera-Gomez, J., Lucas, R. & Butzkueven, H., 1 Dec 2014, In: Annals of Neurology. 76, 6, p. 880-890 11 p.

    Research output: Contribution to journalArticlepeer-review

    47 Citations (Scopus)
  • The autoimmune disease-associated transcription factors EOMES and TBX21 are dysregulated in multiple sclerosis and define a molecular subtype of disease

    Parnell, G., Gatt, P., Krupa, M., Nickles, D., McKay, F., Schibeci, S., Batten, M., Baranzini, S., Henderson, A., Barnett, M., Slee, M., Vucic, S., Stewart, G. & Booth, D., Mar 2014, In: Clinical Immunology. 151, 1, p. 16-24 9 p.

    Research output: Contribution to journalArticlepeer-review

    30 Citations (Scopus)
  • The CYP27B1 variant associated with an increased risk of autoimmune disease is underexpressed in tolerizing dendritic cells

    Shahijanian, F., Parnell, G. P., Mckay, F. C., Gatt, P. N., Shojoei, M., O'Connor, K. S., Schibeci, S. D., Brilot, F., Liddle, C., Batten, M., ANZgene, Stewart, G. J., Booth, D. R. & Slee, M., 15 Mar 2014, In: Human Molecular Genetics. 23, 6, p. 1425-1434 10 p.

    Research output: Contribution to journalArticlepeer-review

    30 Citations (Scopus)